• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

How immune cells switch to attack mode

Bioengineer by Bioengineer
December 17, 2019
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study led by the University of Bonn reveals how macrophages react immediately after contact with bacteria

IMAGE

Credit: © Photo: Rolf Müller/UKB


Macrophages have two faces: In healthy tissue, they perform important tasks and support their environment. However during an infection, they stop this work and hunt down the pathogens instead. Upon coming into contact with bacteria they change their metabolism drastically within minutes. This is shown by a new study under the leadership of the University of Bonn, which has now been published in the journal “Immunity“. In the medium term, the results may lead to new vaccination strategies, but also to new approaches for combating autoimmune diseases.

Macrophages can practically “sniff out” intruders: Their cell surface contains numerous sensors, the Toll-like receptors. These work in a similar way to the olfactory receptors in the nose: They are activated when they encounter a specific chemical signal. The alarm they trigger then leads to a series of reactions inside the cell. “During this phase, macrophages initiate their inflammatory response,” explains Mario Lauterbach, who is completing his doctorate at the Institute of Innate Immunity at the University of Bonn. “How they change their metabolism in the first few minutes and what the consequences are has been unclear so far.”

There are different groups of Toll-like receptors, each of which responds to different “smells”. These are molecules that have emerged as important danger signals in the course of evolution. Among these are the so-called lipopolysaccharides (LPS), important components of the bacterial cell wall. “We have now confronted macrophages with LPS and investigated what happens in the following minutes and hours,” explains Lauterbach.

The scientists were able to show that the cell metabolism changes dramatically shortly after LPS contact: Macrophages immediately absorb more glucose from their environment – but not primarily in order to obtain energy. Instead, they convert the sugar into so-called acetyl groups, which are small molecules related to acetic acid. These then serve as a kind of label in the cell nucleus: They are used to label genome sequences that are supposed to be read more intensively.

Acetyl groups loosen DNA

The DNA is actually a meter-long wafer-thin thread. It would, however, be difficult to store in this form. This is why it is rolled up on many small spools, the histones. Enzymes now attach the acetyl groups to certain parts of the histones. This process is stimulated by the increased acetyl group synthesis after the alarm is triggered, which ultimately loosens the coil of DNA and makes the corresponding genes more readable. “These include genes that are responsible for the release of inflammatory messengers or that improve the mobility of macrophages,” explains Lauterbach.

It has long been known that the activation of Toll-like receptors alters the reading of genes. However, the mechanisms responsible for this differ from the one that has now been discovered. It is likely that this newly discovered mechanism allows the fine regulation of the genetic response. The results may therefore also provide new starting points, such as for improving the effectiveness of vaccinations. Toll-like receptors also play an important role in mediating the “learned” or aquired immune response. This arm of immunity increases the effectiveness of the defense mechanisms against infections that the body has already been through. Vaccinations strategies are also based on this principle.

Possible starting point for new therapies

In many diseases, such as rheumatism, diabetes or multiple sclerosis, the immune response is misdirected or too strong. “The mechanism we discovered might enable us to inhibit harmful inflammatory processes without suppressing the immune system too much,” hopes Prof. Dr. Eicke Latz, head of the Institute of Innate Immunity. Instead of permanently hunting down (non-existent) invaders, the macrophages could concentrate again on their important tasks.

One reason why it was possible to shed light on the immune mechanism is the excellent cooperation between the University of Bonn, the TU Braunschweig and the LMU Munich. This success is also a result of the Cluster of Excellence ImmunoSensation, of which Latz is a member.

###

Publication: Mario A. Lauterbach, Jasmin E. Hanke, Magdalini Serefidou, Matthew S. J. Mangan, Carl-Christian Kolbe, Timo Hess, Maximilian Rothe, Romina Kaiser, Florian Hoss, Jan Gehlen, Gudrun Engels, Maike Kreutzenbeck, Susanne V. Schmidt, Anette Christ, Axel Imhof, Karsten Hiller & Eicke Latz: Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase; Immunity; DOI: 10.1016/j.immuni.2019.11.009

Contact:

Mario Lauterbach

Institute of Innate Immunity at the University of Bonn

Tel. +49-228-287-51227

E-Mail: [email protected]

Prof. Dr. Eicke Latz

Institute of Innate Immunity at the University of Bonn

Co-spokesperson of the Cluster of Excellence „ImmunoSensation”

Tel. +49-228-287-51239

E-Mail: [email protected]

Media Contact
Mario Lauterbach
[email protected]
49-228-287-51227

Related Journal Article

http://dx.doi.org/10.1016/j.immuni.2019.11.009

Tags: Immunology/Allergies/AsthmaMedicine/HealthVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Rising Use of Cannabis for Chronic Health Issues Amid Ongoing Uncertainty

August 1, 2025
blank

March5 Drives Trim28 Degradation to Preserve β-Cells

August 1, 2025

Breakthrough Discovery in Brain Receptors Could Revolutionize Next-Generation Mental Health Treatments

August 1, 2025

Niclosamide Nanohybrid Trial for Mild-Moderate COVID-19

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary AI Technology Paves the Way for Innovative Materials to Replace Lithium-Ion Batteries

Rising Use of Cannabis for Chronic Health Issues Amid Ongoing Uncertainty

Moffitt Cancer Center Initiates Study to Enhance Advanced Lung Cancer Outcomes in Black Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.